par Gnacadja, Sédjio Eustache 
;Hernalsteens, Cédric ;Pauly, Nicolas ;Ramoisiaux, Eliott ;Tesse, Robin ;Vanwelde, Marion
Référence Journal of physics. Conference series, 2420, 1, 012095
Publication Publié, 2023-08-01
;Hernalsteens, Cédric ;Pauly, Nicolas ;Ramoisiaux, Eliott ;Tesse, Robin ;Vanwelde, Marion Référence Journal of physics. Conference series, 2420, 1, 012095
Publication Publié, 2023-08-01
Article révisé par les pairs
| Résumé : | Proton therapy is a well established treatment method for ocular cancerous diseases. General-purpose multi-room systems which comprise eye-treatment beamlines must be thoroughly optimized to achieve the performances of fully dedicated systems in terms of depth-dose distal fall-off, lateral penumbra, and dose rate. For eye-treatment beamlines, the dose rate is one of the most critical clinical performances, as it directly defines the delivery time of a given treatment session. This delivery time must be kept as low as possible to reduce uncertainties due to undesired patient movement. We propose an alternative design of the Ion Beam Applications (IBA) Proteus Plus (P+) eye treatment beamline, which combines a beam-stopping device with the already existing scattering features of the beamline. The design is modelled with Beam Delivery SIMulation (BDSIM), a Geant4-based particle tracking and beam-matter interactions Monte-Carlo code, to demonstrate that it increases the maximum achievable dose rate by up to a factor 3 compared to the baseline configuration. An in-depth study of the system is performed and the resulting dosimetric properties are discussed in detail. |
